Results     07-Feb-15
Announcements
Marksans Pharma consolidated net profit rises 23.31% in the December 2014 quarter
Sales rise 26.39% to Rs 213.29 crore
Net profit of Marksans Pharma rose 23.31% to Rs 27.72 crore in the quarter ended December 2014 as against Rs 22.48 crore during the previous quarter ended December 2013. Sales rose 26.39% to Rs 213.29 crore in the quarter ended December 2014 as against Rs 168.75 crore during the previous quarter ended December 2013.

ParticularsQuarter Ended
 Dec. 2014Dec. 2013% Var.
Sales213.29168.75 26
OPM %24.6021.04 -
PBDT46.1232.67 41
PBT42.1526.97 56
NP27.7222.48 23

Previous News
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 31-May-23   12:46 )
  Marksans Pharma arm receives marketing authorization for Ibuprofen and Paracetamol
 ( Hot Pursuit - 25-Feb-25   12:45 )
  Relonchem receives marketing authorization for Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets
 ( Corporate News - 25-Feb-25   12:31 )
  Marksans Pharma gets EIR from USFDA for Goa facility
 ( Hot Pursuit - 20-Aug-24   14:48 )
  Marksans Pharma to convene AGM
 ( Corporate News - 20-Aug-24   10:46 )
  Marksans Pharma fixes record date for dividend
 ( Market Beat - Reports 24-May-23   17:38 )
  Marksans Pharma standalone net profit rises 45.76% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:41 )
  Marksans Pharma consolidated net profit rises 95.34% in the September 2020 quarter
 ( Results - Announcements 06-Nov-20   15:36 )
  Marksans Pharma gains after receiving final nod for Loratadine Tablets from USFDA
 ( Hot Pursuit - 22-Nov-24   13:23 )
  Marksans Pharma's Verna unit successfully completes USFDA inspection
 ( Corporate News - 20-Aug-24   14:37 )
  Marksans Pharma receives USFDA approval for Loratadine Tablets
 ( Corporate News - 22-Nov-24   12:47 )
Other Stories
  52 Weeks Entertainment reports standalone net loss of Rs 0.07 crore in the June 2025 quarter
  12-Jul-25   14:57
  B2B Software Technologies consolidated net profit declines 41.96% in the June 2025 quarter
  12-Jul-25   14:57
  Sanginita Chemicals standalone net profit declines 64.52% in the June 2025 quarter
  12-Jul-25   07:38
  Avenue Supermarts consolidated net profit declines 0.11% in the June 2025 quarter
  12-Jul-25   07:38
  Emerald Finance consolidated net profit rises 86.55% in the June 2025 quarter
  12-Jul-25   07:37
  Monotype India reports standalone net loss of Rs 0.22 crore in the June 2025 quarter
  12-Jul-25   07:37
  Amal consolidated net profit rises 1988.89% in the June 2025 quarter
  12-Jul-25   07:37
  Swarna Securities standalone net profit declines 28.57% in the June 2025 quarter
  12-Jul-25   07:37
  Nath Bio-Genes (India) consolidated net profit rises 11.78% in the June 2025 quarter
  12-Jul-25   07:37
  Aditya Birla Money standalone net profit declines 5.99% in the June 2025 quarter
  12-Jul-25   07:37
Back Top